Patent · US Active

Reprogramming immortalized B-cells to induced pluripotent stem cells

US8765470B2 · kind B2 · utility

12Cited by
2References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 3, 2011
Grant dateJul 1, 2014
Priority date
Expiry dateApr 16, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2800/108
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Methods and composition for providing induced pluripotent stem (iPS) cells are provided. For example, in certain aspects methods including reprogramming B lymphocytes transformed by episomal vectors such as Epstein-Barr virus-based vectors are described. Furthermore, the invention provides induced pluripotent stem cells essentially free of exogenous elements and having B cell immunoglobin variable region rearrangement.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.